Global Knees grew 5.6% in the quarter with the U.S. growing 3.9% and international growing 8%. Global Hips grew 4%, with the U.S. growing 3.2% and international growing 4.8%. S.E.T. segment grew 8.4%, ...
Stay updated on Zimmer Biomet with Becker's as they report on recent updates, including sales growth, a new acquisition, and a successful surgery.
Zimmer Biomet recently announced entering a definitive agreement to acquire all outstanding common shares of Paragon 28. Under the agreement, ...
The global Bunion Surgery Market, valued at US$437.8 million in 2023, is forecasted to grow at a robust CAGR of 5.7%, ...
NEW YORK, Feb. 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...
BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...
With thousands of press releases published each month, it can be difficult to keep up with everything on . To help healthcare ...
The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of analysts' expectations of $8.56 per share, according to data compiled by LSEG. The ...
Welcome to Zimmer Biomet's fourth quarter 2024 earnings conference ... filings and including those recently filed related to Paragon 28. Please note we assume no obligation to update these forward ...
Q4 2024 Management View CEO Ivan Tornos highlighted that Zimmer Biomet achieved nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid-single-digit or better ...
Zimmer Biomet provided 2025 guidance of constant currency revenue growth between 3%-5% and adjusted EPS in the range of $8.15 to $8.35. These projections exclude the impact of the Paragon 28 ...
Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...